Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of HCL001 cell injection in decompensated cirrhosis
CTR20253647Phase 2Active
- Sponsor
- Shanghai Huicun Medical Technology
- Start
- Sep 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic hepatocyte in Cirrhosis, sponsored by Shanghai Huicun Medical Technology. Started Sep 2025; status: active.
02
Drugs
allogeneic hepatocyte
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on CTR20253647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253647.